Bringing you live news and features since 2006 

James Katz, Humankind

Humankind offers single dollar figure for a company’s social and economic value


Former Vanguard analyst James Katz has founded Humankind Investments, whose first product, the Humankind US Stock ETF (HKND) has just gone over USD100 million in assets.

The firm’s proprietary Humankind US Equity Index tracks the top 1,000 US companies that promote healthier, safer, more equitable and longer lives. The Index’s ranking is based on a quantitative analysis of each company’s positive and negative contributions to society, as measured by its impact on investors, consumers, employees and citizens – defined as its Humankind Value. 

The firm writes that this pioneering concept is captured by a single dollar figure that is meant to represent a company’s true social and economic value to humanity.

Katz says that he got the idea while working for the USD6 trillion asset manager Vanguard. The size of the firm meant that it effectively controlled about 5 per cent of almost every publicly traded company’s shares but, at the time, was not incorporating any kind of ethical or moral policy when voting the shares they managed on behalf of their clients.

“They said it was the asset manager’s fiduciary responsibility to maximise investment returns for shareholders,” Katz says, “and it became clear to me that this was too narrow a definition of what it means to take care of your shareholders.”

“Let’s take an easy punching bag like a tobacco company – you might make USD1,000 in your portfolio over time but maybe someone in your family gets sick from smoking and you have to pay USD10,000 in medical payments. I believe that everyone should take all the economic impacts that companies have outside their portfolio into account.”

Katz felt that this was a niche that was available within a marketing heavy socially responsible investing space.

“I saw this opportunity to try and quantify social responsibility,” he says. “To do the math on how these companies are impacting us outside our portfolios.”

Katz says that the product is aimed at anyone who wants to invest in the US stock market broadly but maximise the benefit of the investments for humanity. 

“The investment thesis is if you believe that society is moving in a more socially responsible direction then people will want to shop at companies doing the right thing, work for companies doing the right thing and that government will regulate companies that are not doing the right thing which will then potentially lead to stronger performance for the investment strategy.”

The firm has other products planned, looking internationally in the next year or so, but Katz comments that the SRI research poses increased challenges in different countries.

Latest News

US ETF issuers of active ETFs are facing an increase in fees from the big custodian firms, such as Charles..
ETF data consultant ETFGI reports that assets invested in the global ETF industry reached a new record of USD12.71 trillion..
Calastone has published an ETF white paper which examines several of the processes that take place across the lifecycle of..
Adapting product lines to fit into changing methodologies and meet shifting demand is essential to remaining relevant in the industry..

Related Articles

Taylor Krystkowiak, Themes ETFs
Themes ETFs opened its doors in December 2023, with an introductory suite of 11 ETFs – seven thematic and four...
Konrad Sippel, Solactive
At the end of March, financial index specialist, Solactive, published its 2024 annual report on future trends.  ...
Lorraine Sereyjol-Garros, BNP Paribas
Following changes to the French Monetary and Financial Code and of the French market authority AMF’s General Regulation, it is...
Ed Rosenberg, Texas Capital
Texas Capital Bank first opened its doors back in December 1998 and nowadays offers wealth-management services, as well as commercial,...
Subscribe to the ETF Express newsletter

Subscribe for access to our weekly newsletter, newsletter archive, updates on the site and exclusive email content.

Marketing by